Merrimack Pharmaceuticals&#44&#59; Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
4 Undervalued Biotech Stocks To Buy Today
Article By: Bret Jensen
Tuesday, June 7, 2016 10:00 PM EDT
The recent brutal bear market in the biotech sector reminded investors in this lucrative but volatile space the imperative importance of risk management when investing in this industry.
In this article: DVAX, MACK, SUPN, ABBV Also: AZN
Read
How To Find Winning Biotech Stocks
Article By: Tracey Ryniec
Monday, April 11, 2016 7:57 AM EDT
If you want to improve your odds of owning a biotech company with a viable drug that it eventually can sell to patients, you should be buying in after the company has passed several of the phases of drug development.
In this article: MACK, JUNO, GNCA Also: BBC
Read
These 4 Stocks Will Lead The Biotech Rally In 2016
Article By: Bret Jensen
Sunday, April 10, 2016 2:48 AM EDT
Their deeply oversold valuations represent amazing long-term entry points as each of these four stocks own products that are going to dominate their niches. Now is the time to buy as the biotech sector starts to rally.
In this article: ACAD, BDSI, DVAX, MACK, RLYP Also: AGN, PFE, IBB, VRX
Read
4 Post-Sell-Off Bargain Stocks In Biotech
Article By: Bret Jensen
Tuesday, August 25, 2015 10:02 PM EDT
The biotech sector, after a miraculous run that saw the main indices shoot up more than 50% in a year until this recent pullback, has given up 15% from its recent peak.
In this article: CLVS, ZIOP, MACK, OMED Also: GSK, AMGN, CELG, GILD
Read
Week In Review: 3SBio Snags Global Rights To MAb For Arthritis
Article By: ChinaBio® Today
Saturday, June 27, 2015 12:16 PM EDT
Materialise, a 3D printing company based in Belgium, agreed to open a multidisciplinary 3D printing center in Fuwai Hospital, a tier three Beijing hospital focused on cardiovascular care.
In this article: MTLS, BAX, MACK
Read

PARTNER HEADLINES

Latest Tweets for $MACK

No tweets yet!